Lowenstein Sandler represented Droit in the transaction. Droit, a technology firm at the forefront of computational law and regulation, announced the closing of a $23 million Series...
Droit Financial Technologies’ $23 Million Series B Investment
Tonix Pharmaceuticals’ Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio
Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) signed an agreement to acquire assets of Healion Bio, Inc., including its...
Infineum USA’s Acquisition of Entegris’ Pipeline and Industrial Materials Business
Wachtell, Lipton, Rosen & Katz advised Entegris, while Lowenstein Sandler advised Infineum on the deal. Infineum and Entegris, Inc. (NASDAQ: ENTG) have entered into a definitive agreement...
Titan’s Partnership with Cathie Wood’s ARK Invest to Launch the ARK Venture Fund
Lowenstein Sandler represented Titan in the transaction. Titan announced its newly announced partnership with Cathie Wood’s ARK Invest to launch the ARK Venture Fund, exclusively available...
VTS’ $125 Million Series E Financing Round
Simpson Thacher advised CBRE Group on the deal, while Lowenstein Sandler represented VTS. View the Space, Inc. (VTS), a leading commercial real estate technology platform that...
LTS Lohmann Therapy Systems’ Acquisition of Tapemark
Lowenstein Sandler represented LTS Lohmann Therapy Systems, Corp. in the transaction. LTS Lohmann Therapy Systems, Corp. (“LTS”) executed its acquisition of Tapemark Inc. (“Tapemark”) located in...
ZyVersa Therapeutics’ Merger With Larkspur Health Acquisition Corp.
Lowenstein represented ZyVersa Therapeutics in the transaction, while Alston & Bird advised Larkspur Health Acquisition Corp. Manatt, Phelps & Phillips advised A.G.P./Alliance Global Partners. ZyVersa Therapeutics,...
Cerity Partners’ Recapitalization
Davis Polk & Wardwell advised Cerity Partners and Lightyear Capital, while Willkie Farr & Gallagher advised Genstar on the deal. Lowenstein represented Cerity Partners EOE LLC....
Dispatch’s $50 Million Series C Funding Round
Lowenstein Sandler represented PeakSpan Capital in the transaction. Dispatch completed its $50 million Series C funding round, led by PeakSpan Capital. Dispatch is a business-to-business delivery platform in which customers...
VTS’ $200 Million Acquisition of Lane Technologies
Osler, Hoskin & Harcourt and Lowenstein advised VTS on the acquisition of Lane Technologies, assisted by Fasken Martineau DuMoulin LLP. On October 19, 2021, VTS announced...
mParticle’s $150 Million Series E Funding
Lowenstein represented mParticle in the transaction, while Fried Frank acted as counsel to Permira. mParticle, the leading customer data infrastructure company, annoounced raising $150 million in Series...
Crown Laboratories’ Acquisition of StriVectin
Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...